mapZambia, with a population of 11.2 million, has an HIV seroprevalence rate of 17 percent. An estimated 1.6 million Zambian adults and 130,000 children are HIV-infected. The disease also has orphaned more than 1.1 million Zambian children.

In 2003, ICAP's MTCT-Plus Initiative began enrolling Zambian families and supporting capacity-building efforts to deliver compehensive, family-based adult and pediatric HIV/AIDS care and treatment services. To this end, ICAP is supporting the development of Centers of Excellence (COE) at Zambia’s University Teaching Hospital (UTH) and Livingstone Hospital. In addition to providing comprehensive pediatric HIV care and treatment services, the centers serve as training facilities for Zambia and neighboring countries. ICAP, which provides a range of technical and logistical support, is supporting the development of a third COE.

In Zambia, ICAP-supported activities include:

  • HIV/AIDS prevention, care, and treatment, including provision of antiretroviral therapy;
  • Integrated tuberculosis/HIV care and treatment;
  • Rapid HIV testing for adults and children;
  • Diagnostic testing/analysis, including Dried Blood Spot DNA PCR testing for infants;
  • Training programs for all cadres of healthcare providers of HIV/AIDS prevention, care, and treatment;
  • Community outreach;
  • HIV support groups, including medication and treatment adherence;
  • Peer education programs;
  • Social services/social support;
  • Nutrition support;
  • Referral services;
  • Home-based/community-based visits;
  • Development and implementation of patient-information systems;
  • Pharmacy services;
  • Laboratory support;
  • Targeted evaluations.